Effects of oestrogen replacement therapy on pattern reversal visual evoked potentials

Area of Science:

• Neuroscience
• Endocrinology
• Ophthalmology

Background:

• Menopause is associated with a significant drop in estrogen levels, impacting central nervous system sensitivity and neurotransmitter function.
• Estrogen influences visual pathway transmission, potentially affecting visual evoked potentials (VEPs).
• Understanding these effects is crucial for managing age-related changes in visual function.

Purpose of the Study:

• To investigate the effect of Tibolon hormone replacement therapy on visual pathway function in post-menopausal women.
• To assess changes in pattern reversal visual evoked potentials (PRVEP) following Tibolon treatment.
• To determine if PRVEP can serve as an objective measure for hormone replacement therapy efficacy.

Main Methods:

• Monocular pattern reversal visual evoked potentials (PRVEP) were recorded in 54 post-menopausal women.
• Measurements were taken before and after treatment with either Tibolon or placebo.
• P100 latency and amplitude values were statistically analyzed.

Main Results:

• Tibolon treatment led to a statistically significant decrease in mean PRVEP latencies (P < 0.001).
• Mean PRVEP amplitudes significantly increased after Tibolon therapy (P < 0.001).
• Placebo treatment showed no significant changes in PRVEP values compared to baseline.

Conclusions:

• Tibolon acts as a sex steroid, accelerating visual transmission time in post-menopausal women.
• PRVEP measurements demonstrate objective electrophysiological evidence of improved visual pathway function.
• PRVEP is a valuable tool for evaluating the effectiveness of hormone replacement therapy in post-menopausal women.